The discovery of a multitude of POLE/POLD1 mutations in human cancers in the 2010s further boosted functional analysis efforts, which now specifically focused on cancer-associated variants with suspected clinical significance [22, 23, 58–85]. This evidence concerns the gene POLD1 and cancer.